We are live on ! Find out more
VA

Verdad Advisers Portfolio holdings

AUM $88.8M
This Fund
S&P 500
This Quarter Est. Return
+13.25%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$88.8M
AUM Growth
+$1.45M
Cap. Flow
-$2.06M
Cap. Flow %
-2.32%
Top 10 Hldgs %
21.25%
Holding
237
New
133
Increased
18
Reduced
23
Closed
58

Top Buys

1
ATHM icon
Autohome
ATHM
+$2.49M
2
BLTE
Belite Bio
BLTE
+$2.32M
3
RVMD icon
Revolution Medicines
RVMD
+$2.18M
4
STT icon
State Street
STT
+$2.13M
5
ZYME icon
Zymeworks
ZYME
+$1.96M

Top Sells

1
C icon
Citigroup
C
+$4.03M
2
TJX icon
TJX Companies
TJX
+$3.81M
3
JNJ icon
Johnson & Johnson
JNJ
+$2.79M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$2.66M
5
CVX icon
Chevron
CVX
+$2.55M

Sector Composition

1 Healthcare 41.87%
2 Technology 13.22%
3 Financials 10.56%
4 Consumer Discretionary 7.94%
5 Communication Services 7.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVT icon
76
Avnet
AVT
$6.95B
$413K 0.46%
6,702
+1,702
+34% +$101K
EWTX icon
77
Edgewise Therapeutics
EWTX
$4.11B
$411K 0.46%
+13,052
New +$376K
VERA icon
78
Vera Therapeutics
VERA
$2.81B
$410K 0.46%
+10,181
New +$439K
CVS icon
79
CVS Health
CVS
$136B
$409K 0.46%
5,700
-10,005
-64% -$771K
WHWK
80
Whitehawk Therapeutics
WHWK
$192M
$398K 0.45%
+115,484
New +$362K
BWA icon
81
BorgWarner
BWA
$12.9B
$394K 0.44%
7,269
-13,571
-65% -$715K
AXGN icon
82
Axogen
AXGN
$2.12B
$381K 0.43%
+11,507
New +$374K
TPH
83
DELISTED
Tri Pointe Homes
TPH
$381K 0.43%
+8,147
New +$331K
FORM icon
84
FormFactor
FORM
$8.35B
$376K 0.42%
+3,877
New +$334K
APEI icon
85
American Public Education
APEI
$939M
$362K 0.41%
+6,367
New +$292K
FIGS icon
86
FIGS
FIGS
$1.72B
$358K 0.4%
+24,251
New +$311K
CCSI icon
87
Consensus Cloud Solutions
CCSI
$700M
$356K 0.4%
15,000
– –
KOD icon
88
Kodiak Sciences
KOD
$2.58B
$347K 0.39%
+9,115
New +$236K
DAKT icon
89
Daktronics
DAKT
$938M
$346K 0.39%
+17,692
New +$404K
SLAB icon
90
Silicon Laboratories
SLAB
$7.2B
$343K 0.39%
+1,650
New +$303K
OVID icon
91
Ovid Therapeutics
OVID
$457M
$337K 0.38%
+151,919
New +$272K
DXC icon
92
DXC Technology
DXC
$1.52B
$335K 0.38%
+26,653
New +$358K
PRDO icon
93
Perdoceo Education
PRDO
$2.04B
$333K 0.37%
8,950
-15,714
-64% -$519K
ARW icon
94
Arrow Electronics
ARW
$10.4B
$333K 0.37%
+2,320
New +$318K
ACLX
95
DELISTED
Arcellx
ACLX
$332K 0.37%
+2,893
New +$255K
RLMD icon
96
Relmada Therapeutics
RLMD
$573M
$328K 0.37%
+47,149
New +$223K
DJCO icon
97
Daily Journal
DJCO
$821M
$328K 0.37%
+679
New +$371K
SUPN icon
98
Supernus Pharmaceuticals
SUPN
$2.8B
$325K 0.37%
+6,295
New +$321K
MSB
99
Mesabi Trust
MSB
$323M
$325K 0.37%
10,303
-9,264
-47% -$315K
NSSC icon
100
Napco Security Technologies
NSSC
$1.31B
$319K 0.36%
+8,091
New +$339K
2 3
4
5 6

Similar funds

CAM
Capital Asset Management Denver, Colorado $88.8M AUM
SCA
Sassicaia Capital Advisers Jericho, New York $88.8M AUM 146.47% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $88.9M AUM
HI
Hyundai Investments Yeongdeungopo-Gu, Seoul, South Korea $88.7M AUM 25.11% 1-Year Est. Return
XFP
Xena Financial Planning Portland, Oregon $88.6M AUM
UCM
Up Capital Management Roseville, California $89.1M AUM
BLC
Blue Line Capital Chicago, Illinois $88.4M AUM
BC
Bayforest Capital London, United Kingdom $89.3M AUM 33.7% 1-Year Est. Return

Verdad Advisers's Q1 2026 Portfolio in Review

As of Q1 2026, Verdad Advisers held 237 positions worth $88.8M, up 1.7% from $87.4M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Verdad Advisers's Q1 2026 filing shows 133 new, 18 increased, 23 reduced and 58 closed positions. Its largest new stake was Autohome: 121,317 shares worth $2.11M. The largest sale was Citigroup, an estimated $4.03M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 12% a quarter earlier, followed by Technology and Financials.

  • Verdad Advisers's largest Q1 2026 buy was Autohome: 121,317 shares worth $2.11M.
  • Verdad Advisers added most to California Resources in Q1 2026, an estimated $867K increase.
  • Verdad Advisers's biggest Q1 2026 reduction was Johnson & Johnson, cutting an estimated $2.79M.
  • Verdad Advisers fully exited Citigroup in Q1 2026, selling an estimated $4.03M.
  • Verdad Advisers's ten largest holdings make up 21% of its $88.8M portfolio in Q1 2026.
  • Verdad Advisers opened 133 new positions and closed 58 in Q1 2026.
  • Verdad Advisers's portfolio value rose 1.7% quarter-over-quarter to $88.8M.

Based on Verdad Advisers's 13F filing for Q1 2026, filed 15 May 2026.